A novel chemotherapeutic protocol for peritoneal metastasis and inhibition of relapse in drug resistant ovarian cancer. [electronic resource]
Producer: 20191114Description: 3630-3641 p. digitalISSN:- 2045-7634
- Animals
- Antineoplastic Agents -- administration & dosage
- Cell Line, Tumor
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Female
- Humans
- Irinotecan -- administration & dosage
- Mice
- Neoplastic Stem Cells -- metabolism
- Oligopeptides -- administration & dosage
- Ovarian Neoplasms -- pathology
- Peritoneal Neoplasms -- drug therapy
- Spheroids, Cellular
- Treatment Outcome
- Tumor Cells, Cultured
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.